BioAge Labs, Inc (BIOA) is a drug manufacturers - specialty & generic company listed on US.
Latest reported BIOA revenue for 2025-12-31 was $9.0M. Net income was -$80.6M. BIOA currently screens at market cap $697.9M.
Use this BIOA page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the BIOA quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the BIOA SEC filings page. Lician reads the product cache first so this HTML stays unique to BioAge Labs, Inc even when a live quote feed is slow.
Latest cached year on this hub. Full BIOA income, balance, and cash tables.